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Abstract
Interfacial tissue engineering is an emerging branch of regenerative medicine, where engineers are
faced with developing methods for the repair of one or many functional tissue systems
simultaneously. Early and recent solutions for complex tissue formation have utilized stratified
designs, where scaffold formulations are segregated into two or more layers, with discrete changes
in physical or chemical properties, mimicking a corresponding number of interfacing tissue types.
This method has brought forth promising results, along with a myriad of regenerative techniques.
The latest designs, however, are employing “continuous gradients” in properties, where there is no
discrete segregation between scaffold layers. This review compares the methods and applications
of recent stratified approaches to emerging continuously graded methods.
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INTRODUCTION
The course of tissue engineering and regenerative medicine over the last decade has been
nothing short of remarkable, and at the current rate of new discoveries and questions, one
must wonder whether scientists and engineers will ever run out of phenomena to investigate.
Researchers are familiar with the greater purposes: to understand natural phenomena, to
translate knowledge into application, and to adapt applications for the benefit of others.
Anatomy and physiology are taught such that there are a defined number of tissue types, and
a corresponding set of tissue interfaces. Yet, just because tissues are separated from one
another by type, function, location, or anatomical prevalence, does not necessarily mean that
the interfaces are as easily distinguishable, as the interfaces themselves are highly complex.
Interface tissue engineering has emerged as a subset of functional tissue
engineering.4,17,29,45 Functional tissue engineering involves hierarchical examination of
native tissues from the molecular level upward, carefully characterizing tissue structure to
identify essential relationships between structure and function, and translating these
relationships to scaffold formulation and application. Interfacial tissue engineering
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introduces another variable: the interface, the study of two or more structure–function
relationships performing together in unison.
The concept of using different structures, materials, and cell sources for bulk tissues has
gained appreciable support. Most approaches that directly target tissue engineering of
interfaces have been stratified in nature. Stratified scaffolds utilize two or more discrete
layers of differing physical or chemical properties (Fig. 1). Because of this definition,
technically, any three-dimensional (3D) multiphasic construct approach could be considered
to be “graded,” and many groups are now referring to even biphasic designs as such.
Biphasic and other interfacial designs for bone, cartilage, ligaments, tendons, and other soft
tissues have been reviewed eloquently and thoroughly, along with detailed analyses of the
respective anatomical attributes of the native tissues.6,9,16,22,26,28,32,35,39–42,49,54,70 Hence,
this review will not attempt to re-address all previously reviewed methods, and will focus
instead on recent stratified orthopedic investigations outside of meniscus–bone and muscle–
tendon solutions, for which there are a limited number of current tissue engineering
solutions (see review 70). In addition, the relevance and distinct advantages of stratification
in vascular systems will be presented with recent examples of how these interfaces can be
formed. Of foremost importance, however, is an introduction to the emerging approach of
using continuously graded 3D designs for orthopedic interface tissue engineering (Fig. 1),
urging readers to revisit traditional multiphasic designs for critical comparison between the
two methods.
GRADIENTS IN TISSUE ENGINEERING
Singh et al.56 and others15,35,48 have compiled comprehensive reviews on state-of-the-art
applications for incorporating gradients in tissue engineering, illustrating numerous current
and potential strategies for interfacial tissue engineering. Basic concepts for formulating
multiple tissue systems42 rely on one or more forms of chemical or physical stimuli, which
affect cell-specific movement, substrate affinity, or tissue formation.56 Furthermore, the
majority of two-dimensional (2D) gradients utilizing these techniques have been intended
for simply characterizing tissue engineering phenomena in the form of high-throughput
screening, and have not necessarily been translated to 3D interfacial tissue applications. In
addition, the resolution of native interfaces can take many forms, as primary interfaces (such
as between soft tissue and bone, muscle, and tendon), or subsidiary interfaces (among
articular cartilage layers, mineralized, and non-mineralized layers of fibrocartilage, tunicae
of the vasculature, and dermal layering), which may imply a need for analogous resolution
in the form of either stratified scaffolds or continuously graded approaches.
STRATIFIED INTERFACES
Recent stratified interfacial designs have focused on porosity or pore size,21,37,38,66 matrix
proteins, 37,43,61,62,67 mineral,37,38,61,62,67 and bioactive factor 62 incorporation to resolve
transitioning orthopedic tissue structures. There also exist stratifications of cell types2,14,33
or other features7,20,24,27,63,71 for vasculature network interface formation. Although it could
be argued that a stratified approach does not yield a “true” continuous gradient, it can have
many discrete advantages over continuous gradients. Because of the inherent discontinuous
fabrication methods (developing sections separately and fusing together), however, design
effort must be placed on ensuring that the interfacing layers are interconnected. Some
emerging interfacial tissue engineering solutions currently exist only as methods, whereas
others have been tested for their biological relevance in vitro or in vivo. The following
sections review some recent design concepts and tissue regeneration on stratified constructs.
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The Cortical–Cancellous Bone Interface
There exist many morphological and physiological characteristics of bone, such as osteon
and Haversian canal localization to the cortical region, and marrow localization to the
cancellous region. Tissue engineering solutions for this interface, however, rely largely on
the differences in porosity and mineralization. For instance, a critical factor in designing
constructs for bone tissue engineering is ensuring proper osseointegration within the host. A
relevant method for accomplishing this comes from mineral incorporation within the
scaffold itself. Ample evidence exists in the bone biology and tissue engineering literature
for calcium-based minerals8,10,52 promoting osteoblastic behavior and the rate of in situ
bone matrix formation, as variations of these minerals are already present in the native
tissue. On a larger scale than seen in most tissue engineering applications, Hsu et al.21
demonstrated how to fabricate a composite scaffold mimicking the change in porosity
among the cortical–cancellous bone interface, composed of only hydroxyapatite (HA), and
tricalcium phosphate (TCP) (Table1). Polyurethane foams were either stitched or press-fitted
together, then vacuum impregnated with HA and TCP, or dipped in ceramic slurry.
Following drying, the polyurethane was removed by burnout. The resulting structure
reflected a biphasic porosity, similar to the native tissue morphology, and four point bending
tests suggested that the interface between the two layers was robust. However, the influence
of this particular interface on in vitro and in vivo performance has yet to be demonstrated.
Using bioactive glass composites for bone tissue engineering,1,23,64,65 specifically for
mimicking the cortical–cancellous interface, is another method of interest, due to favorable
biocompatibility and to moduli similar to native bone tissue. Vitale-Brovarone et al.66 used
such a material to fabricate six different stratified porosity patterns (Table 1). Blocks of
higher porosity were fabricated by burnout of polyethylene particles or polyurethane
sponges from dried bioglass mixtures. Low porosity samples were made by layering and
compressing the bioglass mixture. The resulting bi-porous composites were made by heat
sintering sections together. These constructs were then subject to unconfined compression or
cultured for a short period in simulated body fluid (SBF). The interfaces between porous
regions were well integrated morphologically, and testing did not indicate that this area was
a specific structural weakness. Incubation of the high porosity stratified constructs from
sponge replication in SBF showed HA formation on the surface after only 7 days.
Just as with Hsu et al.’s approach,21 full in vitro characterization is needed to evaluate the
effectiveness of this stratified technique for cortical–cancellous interface tissue engineering.
With both techniques, an effective design to eliminate interface delamination was proposed,
which is an important theme in stratified approaches to interfacial tissue engineering.
The Ligament/Tendon–Bone Interface
The bone-to-ligament interface (similar in many respects to the tendon–bone interface70) is
comprised of mineralized (hypertrophic chondrocytes and collagen type X) and non-
mineralized (ovoid chondrocytes and collagen types I and II) regions of fibrocartilage.
Flanking this fibrocartilage interface are the ligament proper (fibroblasts) and subchondral
bone (osteoblasts, osteoclasts, and osteocytes). This interface is unique, in that it is a more
anatomically and physiologically distinguishable region than between cortical and
cancellous bone, for instance. In fact, subsidiary interfaces exist within this interface, as
between the non-mineralized and mineralized fibrocartilage. Furthermore, the bone-to-
ligament transition can provide valuable information on how to approach all stratified
orthopedic interfaces, addressing the issues of whether multiple tissue segments should be
regarded as one large interface (or perhaps two, maybe three interfaces), and how one
should formulate a scaffold design.
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Munoz-Pinto et al.46 recently introduced a method for ligament-to-bone interface tissue
engineering using hybrid hydrogels of poly(ethylene glycol) (PEG) and star
poly(dimethylsiloxane) (PDMSstar) (Table 1). A stratified or graded construct was not
explicitly fabricated, but the authors characterized the effects of PDMSstar-to-PEG weight
ratio on osteoblast phenotype, gene expression, and biochemical production. With increasing
inorganic (PDMSstar) content, there was a decrease in bone-like matrix and an increase in
cartilage-like matrix.
Lu’s group39,40 has made considerable and detailed progress with addressing functional
tissue regeneration of the bone-to-ligament interface. For example, a notable in vitro
investigation by Wang et al.,68 using co-culture of fibroblasts and osteoblasts, emphasized
the extensive influence that adjacent tissues have on forming the fibrocartilage interface
(Table 1). Not only did overall cell proliferation decrease during co-culture, compared to
culturing osteoblasts and fibroblasts separately, mineralization was also diminished in
osteoblasts and enhanced in fibroblasts. Both cell types showed upregulation of genetic
markers pertinent to the interfacial tissue, but a specific fibrocartilaginous interface was
never formed. The absence of a fibrocartilaginous interface was also observed on a novel 3D
triphasic construct during co-culture conducted by Spalazzi et al.,60 where an entire scaffold
segment was dedicated to the interface. With all evidence indicating a missing aspect for
formation of a fibrocartilage area, studies continued using co-culture and tri-culture of
differing cell types (with chondrocytes for the interfacial region) in vivo (Table 1).45,59
Interestingly, tri-culture succeeded in forming a fibrocartilage region along with interface-
relevant tissue matrix. However, this fibrocartilage was not fully localized to the intended
middle phase of the scaffold (Figs. 2a and 2b). The authors acknowledged a limitation
relating to scaffold production and chondrocyte seeding, and hinted at future methods for
mitigating chondrocyte migration (and subsequent fibrocartilage formation) outside of the
center of the construct. It could be concluded, perhaps, that more than one region of the
construct was conducive to successful fibrocartilage formation.
In summary, efforts to regenerate the ligament–bone interface have included 2D and 3D
studies to guide scaffold design. Important factors in the analysis of these designs have
included the examination of how interfacing cell types react genetically, biochemically, and
histologically to each other’s presence.
The Cartilage–Bone Interface
The cartilage-to-bone interface is comprised of several layers of collagen fibrils, with
increasing chondrocyte density, and decreasing aggrecan content, approaching the articular
surface. This articular surface is composed primarily of collagen type II, whereas the
subchondral bone layer consists of osteoblasts, osteoclasts, and chondrocytes embedded in
collagen type I and calcium-based minerals. Traditionally, cartilage-to-bone applications
have used biphasic constructs to mimic the transition from chondrocytes in articular
cartilage to osteoblasts in subchondral bone.22,26,41,49 Triphasic methods can introduce
higher interfacial resolution, where a middle scaffold phase is incorporated to mimic the
calcified cartilage transition region near the native osteochondral tidemark. Many
applications even address subsidiary interfaces between individual cartilage layers.28 The
following is an overview of the latest stratified osteochondral applications.
As noted, type I collagen incorporation for bone tissue engineering is gaining considerable
attention, due to its ability to modulate cellular adhesion and phenotypes,11,18,44,47,53 aside
from being the most abundant collagen in bone tissue. Wahl et al.67 presented a method for
incorporating HA and type I collagen within shape-specific scaffolds via solid freeform
fabrication (SFF). Using varying collagen concentrations, a stratification in pore size and
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porosity was achieved, where porosity was inversely proportional to Young’s modulus
(Table 1), just as seen in Vitale-Brovarone et al.’s66 application.
Similarly, Liu et al.37 used multinozzle low-temperature deposition manufacturing (M-
LDM) with collagen type I, chitosan, gelatin, TCP, and poly(D,L-lactic-co-glycolic acid)
(PLGA) to create extremely complex interfacing surfaces for use with virtually any tissue
engineering application (Table 1). Scanning electron microscopy (SEM) revealed that
integration between natural and synthetic polymers was feasible, and the authors highlighted
the ability to possibly interface materials with differing hydrophilicities, which could
influence fluid dynamics, nutrient exchange, and biodegradation within any given construct.
Recently, the same group conducted an in vivo study aiming to recreate the bone-to-
cartilage transition with a triphasic composite.38 In addition to having triphasic porosity,
there was also a stratification in materials (Table 1). After 6 weeks in a rabbit model, the
scaffold performed favorably overall compared to a sham procedure, with a sharp transition
between in situ tissues, instead of a stratification of mineralization.
Ho et al.19 utilized a biphasic construct with a change in porosity and TCP concentration,
then implanted the scaffolds into porcine defects of the medial and patellar condyles (Table
1). Extensive characterization revealed that the presence of transplanted cells was beneficial
compared to having just the scaffold.
Mimura et al.’s43 design used a radial change in collagen, with a higher collagen
concentration in the scaffold center, to induce mesenchymal stem cell (MSC) migration to
the center of full-thickness osteochondral defects as a possible treatment for injuries that are
beyond the critical limit (Table 1). It was found that a step change of 33% collagen
concentration was more effective at regeneration than a change of 50%, demonstrating that
the benefits of stratification were not strictly proportional to the magnitude of change in
chemical composition between layers.
Common materials for hard tissue engineering, such as chitosan and HA, can also be used in
stratified designs for bioactive factor release. Teng et al.62 fabricated a radial change in
material and porosity, which subsequently influenced the release of tetracycline
hydrochloride from a core structure (Table 1). Having several layers of a porous construct
could not only allow for cell penetration and tissue growth, but also for sequential delivery
of growth factors to the site of regeneration.
In another triphasic design for osteochondral defects, layers of differing collagen type I and
HA content were used to create a stratification of mineralization (Table 1).61 Although, in
vitro, constructs were shown to favor chondrocyte matrix deposition only in the cartilage-
like layer, tissue regeneration in vivo resembled two distinct tissue regions resembling bone
and a cartilage-like tissue (Figs. 2c and 2d). Similarly, in a clinical study, Kon et al.31 used a
triphasic scaffold, with a stratification of collagen I and HA, in 13 patients with
osteochondral knee lesions (Table 1). Results of gross tissue regeneration and implant
stability at 6 months were encouraging although the long-term clinical implications for this
method, as other discussed orthopedic applications, are currently unknown.
In conclusion, stratifications of mineral content, collagen, and porosity are common
approaches for osteochondral regeneration. In addition, it should be noted that SFF or M-
LDM could be used to create not only layered designs (as seen here), but also continuous
gradients, as it is a time-dependent and highly customizable process.
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Vasculature Tissue and Network Interfaces
Tissue engineering of the vasculature with stratified scaffold designs is a relatively recent
development. Anatomically, there exist three primary tissue layers in arteries and veins: the
tunica externa (loose fibrous and connective tissue), the tunica media (smooth muscle), and
the tunica intima (endothelial cells). Regeneration of such layers has great potential for
traditional bypass techniques. In addition, these vessels are located throughout the body,
creating a network for nutrient exchange. Thus, there are also interfaces between vessels and
bulk tissue, where stratification is used to mainly recreate network hierarchies, as opposed to
tunicae layers. Recent methods focus on regenerating both of these interface types.
For vascular layering, Thomas et al.63 used electrospinning to fabricate a tri-layered annular
construct with a shallow radial change of porosity and mechanical properties, accomplished
by transitioning between mass ratios of gelatin or elastin embedded in a bio-artificial
polyglyconate (Table 2). Subsequent biodegradation studies demonstrated reduced
mechanical integrity and inner layer delamination by 3 weeks, although the constructs still
maintained a tensile strength near that of the native femoral artery.71
Gauvin et al.14 developed a cell-only single-step method for recreating small-caliber arterial
grafts (a tunica media and intima) with layers of dermal fibroblasts and smooth muscle cells
(SMC) (Table 2). The two cell types were cultured adjacently to each other and allowed to
integrate for 28 days, and were then rolled onto a tubular support; SMC first, then fibroblasts
(Fig. 3a). After the constructs were cultured for 14 days, mechanical testing demonstrated
enhanced ultimate tensile strength, burst pressure, and linear modulus compared to rolling
the two layers separately.
Kim et al.27 utilized a poly(L-lactide-co-ε-caprolactone) (PLCL) solution spun onto a
tubular shaft in a non-solvent to create a bi-layered pore stratification (Table 2). The shaft
was pre-treated with sodium chloride (NaCl), which became incorporated with the inner
layer of the PLCL fibers during deposition. The salt was leached out following fabrication,
creating smaller pores on the inner layer, whereas fiber collection on the outside formed
larger pores. Mechanical testing revealed circumferential and longitudinal tensile strengths
that were superior to those of the canine abdominal aorta.
Ju et al.24 created a 3D bi-layered scaffold with poly(caprolactone) (PCL) and collagen via
electrospinning (Table 2). A change in fiber diameter, and subsequent change in pore
volume, was created by layering different concentrations of PCL and collagen in a solvent.
Mechanical testing showed that smaller fiber diameters had higher ultimate tensile strengths,
elastic moduli, and percent elongations at failure. In addition, the construct was able to
localize endothelial and SMC to the different layers.
Other techniques focused on creating neo-synthesized tissue networks, and stratified designs
in bioactive factors can be used to address the intricacies of forming such interfaces within a
bulk tissue. The relevance of this hierarchy in patterning blood vessel formation was fully
appreciated by Chen et al.7 (Table 2), in atypical applications of stratified scaffolds that they
recognized earlier.51 Their investigation was particularly unique for two reasons. Firstly, a
stratified scaffold design was used to introduce a spatial element to temporal formation, and
maturation, of neo-synthesized blood vessels. Secondly, while growth factor loading was
biphasic in nature, a continuous gradient in concentration existed when the proteins were
eluted.
Another recent method for pre-vascularization of tissues was introduced by Asakawa et al.2
by layering of only fibroblasts and endothelial cells in alternating patterns (Table 2). A fibrin
gel was used to fuse cell layers with a plunger and dish apparatus. The method demonstrated
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that the cell types remained within their intended stratified regions, and endothelial cell
placement controlled the size and location of lumen formation within the construct (Fig. 3b).
Similar methods in epidermis printing have the potential to be used in vasculature networks
as well, as these are contiguous tissue components in the body. Recently, Lee et al.33 created
a ten-layer construct for epidermis grafting. Even though some layers were identical in
composition, the technique enabled the isolation of fibroblasts or keratinocytes to 300 μm
slices, with the whole construct being less than 3.0 mm in thickness (Table 2). Fluorescent
labeling confirmed cell localization to the intended layers. In this case, having a continuous
gradient along the depth of the construct would not allow for isolated cell printing, where
perhaps many layers of different cell types, or discretely controlled cell densities, would be
possible. Although not directly applied to graded interface tissue engineering, recent
applications using two-photon laser scanning photolithographic techniques in bioactive
hydrogels could be similarly applied for 3D migration and localization of cell populations.34
Finally, stratifications in microvascular density can be used to address organ-wide
regenerative therapies. A notable and recent computer-aided design created radial changes in
vascular diameter, length, and density to mimic the venous architecture of a liver lobule
(Table 2).20 Sheep’s blood was pumped through molded PDMS in vitro to simulate native
blood flow. Interestingly, the stratification of physical dimensions created a continuous
pressure gradient across the assembly, all while minimizing the variation of shear stress at
the wall (Fig. 3c). This method could also have large-scale potential, as multi-layering of
such radial networks could create 3D stratifications.
Furthermore, a stratified approach for vascular interfaces may prove to be superior to a
continuously graded one, as localization of specific cell types and tissue morphologies to
different regions of regenerated vessels is crucial to prevent blood leakage, maintain
mechanical integrity, and to create high resolution in these networks with cellular layering.
Summary of Stratified Designs
In summary, stratified 3D scaffold designs for interfacial tissue regeneration are being used
diversely, with most applications generating improvements in mechanical properties and/or
tissue integration. There exist simple fabrication methods that mimic a structure–function
relationship for the cortical–cancellous interface, or add even more complexity to this
structure–function with time-dependent or protein- and mineral-based processes for
cartilage–bone and ligament–bone interfaces. In addition, novel applications capitalizing on
the aspect of having compartmentalized regions, such as in de novo vascular formation,
endothelial cell layering, epidermal printing, and vascular network hierarchies, may be
comparable or superior to continuous gradient approaches. Another distinct advantage of
stratified designs is for bioactive factor encapsulation, where layering can provide a delayed
release or multiple specific sequential release rates. The key issue, however, is how much
influence the physical or chemical characteristics of the whole construct have on the
regeneration of the interfacial region. Studies reviewed here, along with reviews of other
stratification methods,26,28,41,49,70 have made it possible for tissue engineers to begin to
critically assess the performance of stratified interface designs for specific applications,
compared to continuously graded approaches. Specifically, as observed in some in vivo
orthopedic applications highlighted earlier,38,59,61 the morphology or occurrence of neo-
tissue formation is not necessarily dependent upon stratified scaffold design intricacies. This
does not imply that material selection or characteristics are irrelevant, but perhaps specific
physical, chemical, or topological properties can be utilized continuously in such a way that
is conducive to multiple tissue formation in one seamless construct. Such concepts are
gaining attention in the tissue engineering community, and with a burgeoning number of
continuously graded 3D designs for interfacial strategies.
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Here, a diverse sampling of methods for creating continuous 3D gradients for interfacial
tissue engineering is presented. Recent methods employed gradients in transcription
factors,50 nanoparticle incorporation,13 porosity,5 bioactive factor release,58,69 and HA
precipitation.36 There exists a myriad of continuously graded 2D and 3D studies56 that have
been used in modifying surface chemistry or quantifying cellular guidance, applied to
implant design, or simply inferred for potential use in tissue engineering applications.
Fabrication methods for creating changes in porosity and pore size need not be a multiple
step process. For example, Bretcanu et al.5 utilized a bioactive glass and heat treatment,
along with an aluminum mold, to fabricate a continuous gradient in porosity (Table 3). With
this method, a gradient could theoretically be created in any direction, at any length, creating
narrow or broad pore size ranges. Once the pore gradient is made, a construct of any shape
could be extracted. This type of fabrication might be most useful in filling longitudinal-,
wedge-, or cubicalshaped defects that penetrate a small volume of cortical and cancellous
bone. Full circumferential recreations of the cortical–cancellous interface, as seen previously
with stratified techniques,21,66 may be more difficult to recreate. Additionally, the in vitro
and in vivo potential has yet to be evaluated.
The incorporation of calcium-based additives along with proteins or polysaccharides is a
recurring theme for osteochondral applications, as seen in this review alone.37,38,61,62,67
Recently, Liu et al.36 proposed a method for creating a collagen scaffold with a gradient of
HA (Table 3). Fabrication was based upon a modified diffusion method, where phosphate
and calcium ions migrated down their respective concentration gradients, across the base
construct. Depending on the concentration of calcium in any given region, different
morphologies of HA crystals were formed, and the overall porosity was controlled by
collagen content.
Electrospinning is another time-dependent process that makes fabrication of continuously
graded scaffolds possible. Erisken et al.13 used a twin-screw extrusion process with PCL to
create a continuous gradient of TCP nanoparticles (Table 3). The presence of a TCP gradient
was evident through SEM and Von Kossa staining. Due to incorporation of a stiff
nanomaterial, the scaffolds were also functionally graded, which was verified by mechanical
testing. In addition, the compressive modulus and toughness of the graded constructs
increased considerably after culture with pre-osteoblasts.
Singh et al.58 presented the first report of a technique for formulating a continuous 3D
gradient in bioactive factors using microspheres.58 Using programmable pumps and a
precision particle fabrication process that created monodisperse microparticles, an axial
gradient in volumetric composition was made (Table 3). Although the initial
characterization included only microspheres loaded with rhodamine dye to demonstrate the
gradient profile, essentially any bioactive factor could be encapsulated in either side [e.g.,
bone morphogenetic protein (BMP)-2 and transforming growth factor (TGF)-β1 for a bone–
cartilage interface], formulating opposing gradients for interface generation. Recently, the
same technology was used to encapsulate titanium dioxide (TiO2) and calcium carbonate
(CaCO3), formulating a gradient in stiffness.57 Combining a stiffness and growth factor
gradient could also be achieved with this process, along with many types of microsphere
formulations (double-walled, 30,72 porous,3,25 or with HA55). Recently, Dormer et al.12
completed an in vitro characterization of the microsphere-based gradient design, where
opposing growth factor gradients of TGF-β1 and BMP-2 produced regionalized extracellular
matrix and outperformed the blank control scaffolds in biochemical production and gene
expression of some major osteogenic and chondrogenic markers (Table 3).
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Recently, Wang et al.69 presented a gradient microsphere method, but suspended PLGA or
silk microspheres inside silk or alginate gels with MSCs. Using BMP-2 and insulin-like
growth factor (IGF)-1, single or opposing gradients were made to regenerate the soft tissue-
to-bone transition (Table 3). Most notably, the study found that opposing (dual) gradients in
bioactive signaling increased GAG and calcium content, along with collagen I and II gene
expressions, compared to groups having only a single growth factor gradient. With this
method, a bioactive gradient may be better maintained over time, as the gel environment
may mitigate rapid growth factor diffusion out of their respective regions of the construct.
Lastly, Phillips et al.50 presented a method for localizing continuous gradients onto
interfacial constructs, and not relying on growth factor elution to induce cell differentiation
(Table 3). Using a time-dependent dipping procedure with a motorized dip coater, a gradient
of retrovirus encoding runt-related transcription factor 2 (Runx2) was deposited on top of a
gradient of poly(L-lysine). The gradient was oriented along the length of the collagen
scaffold. When seeded with fibroblasts, the construct was successful in creating a gradient of
osteoblastic differentiation (osteoblasts and fibroblasts on one construct). When the
scaffolds were evaluated in vitro and in vivo for mineral deposition, the in vivo mineral
distribution appeared to be more biphasic in nature after just 2 weeks, whereas the in vitro
constructs maintained a more continuous mineral gradient for 42 days (Fig. 4). The in vivo
behavior is reminiscent of an application for ligament–bone interface engineering59 and
other cartilage–bone applications,38,61 where tissue generation patterns did not necessarily
adhere to the initial scaffold design. In addition, Phillips et al.’s50 technique induced a
functional gradient from a strictly biochemical surface gradient.
Summary of Continuous Gradients
In summary, techniques to create continuous 3D gradients for orthopedic interface tissue
engineering generally involve a time-dependent process, as do the more complex stratified
designs. Incorporation of bioactive factors can have varying levels of control over the
effective region, either by release directly into the cell culture medium, into a gel network,
or being completely immobilized on a substrate. In vitro, continuous gradients thus far have
demonstrated continuous gradients of tissue-specific matrix as intended; however, in vivo, a
continuous design may abandon its original continuous gradation, as it becomes subject to
cascades of native biological processes that define location and morphology of the interface.
Specifically, a gradient approach could provide more regenerative control to nature, using a
continuous transition of signals, directing the interface to form in a specified region, which,
ultimately, may be conducive to custom-made, patient-specific regenerative designs.
Methods for creating such smooth, seamless transitions between tissue regions are not
necessarily more elaborate, or time-consuming, than their stratified counterparts.
CONCLUSION
As tissue engineering and regenerative medicine moves forward, the search continues for
missing ingredients in regenerating ideal tissue interfaces, a process that must take tissue
functionality into consideration (Fig. 5). What are these missing elements for interfacial
tissue engineering? In some instances, as seen in this review, the missing elements could be
one or several things (e.g., simply taking the design from 2D to 3D or from in vitro to in
vivo environments, adding an extra cell type or bioactive substrate, a slower release profile
for a growth factor, or a combination of these). After several iterations of this process,
researchers will be able to determine a minimum formulation of concerted regenerative
signals, such as (1) critical physical morphologies like pore size or porosity, (2) specific
concentrations, locations, or temporal release profiles of bioactive signals, (3) essential bulk
material properties such as mineral density or protein content, and (4) all of the
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aforementioned characteristics presented in a stratified manner or continuously graded
fashion for multiple tissue regeneration (Fig. 5).
While stratified and continuous scaffold designs have primarily been employed in
orthopedics, new applications of these interfacial gradient designs (e.g., vascular
regeneration) are rapidly growing. Stratified and continuous scaffold designs each have their
advantages. For example, stratified techniques can have specialized applications for
localization of endothelial or epithelial cell populations, creating discrete sequences of drug
release, or large-scale vascular network patterning. In addition, depending on available
equipment, the technology to create continuous gradients may not be available. However,
there are numerous instances where equipment being used for fabricating stratified scaffolds
could easily be adjusted to create continuous gradients (e.g., various SFF methods). In
contrast, continuous gradient designs represent a seamless interfacial transition that better
approximates the gradual, rather than sharp, interface between native tissues. Only time will
tell whether continuous or stratified scaffold designs will provide better results in vivo, or
whether one may be more well suited than the other depending on the specific application.
Nevertheless, continuously graded designs may represent the next generation of interfacial
tissue engineering solutions.
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Scaffold morphology for interface tissue engineering has continued to use biphasic and
triphasic solutions, although some have advanced toward multilayered approaches.
Continuously-graded designs attempt to make higher resolution in physical and chemical
properties.
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Scaffolds (a, c) and regenerated tissues (b, d) in interface tissue regeneration. (a) Triphasic
scaffold for ligament–bone interface engineering, where Phase A was designated for the
ligament proper, Phase B for the fibrocartilage interface, and Phase C for subchondral bone.
(b) Fibrocartilage formed (arrow) in vivo during tri-culture with fibroblasts, chondrocytes,
and osteoblasts, but was not localized strictly to Phase B. Scale bar = 500 μm in each panel.
(c) Triphasic collagen/HA scaffold for osteochondral regeneration. Scale bar = 500 μm. (d)
Bone-like and cartilage-like tissues regenerate successfully, but transition is not gradual.
Scale bar = 1.0 mm. (a) Reprinted from J. Biomed. Res. A/86, Spalazzi, J., E. Dagher, S.
Doty, X. Guo, S. Rodeo, and H. Lu, In vivo evaluation of a multiphased scaffold designed
for orthopaedic interface tissue engineering and soft tissue-to-bone integration, 1–12,
Copyright (2008), with permission from John Wiley and Sons; (b) Reprinted from Clin.
Sports Med./28, Moffat, K., I. Wang, S. Rodeo, and H. Lu, Orthopedic interface tissue
engineering for the biological fixation of soft tissue grafts, 157–176, Copyright (2009), with
permission from Elsevier; (c, d) Reprinted from Biomaterials/29, Tampieri, A., M. Sandri,
E. Landi, D. Pressato, S. Francioli, R. Quarto, and I. Martin, Design of graded biomimetic
osteochondral composite scaffolds, 3539–3546, Copyright (2009), with permission from
Elsevier.
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Recent methods for creating stratifications in vasculature interfaces and networks. (a)
Single-step method for creating layered vascular tunicae from SMC and fibroblasts cultured
adjacently (ssTEVMA: single-step tissue-engineered media and adventitia); (b) placement of
endothelial cells (EC) below fibroblasts (Fb) promotes lumen formation (green) inside
fibroblastic bulk tissue (red) as early as 7 days; (c) computer-generated stratifications of
vascular patterns can be used with soft lithography to generate 2D, or eventually 3D, organ-
level networks, which deliver continuous pressure gradients and a narrow range of shear
stress. (a) Reprinted from Tissue Eng. A, Gauvin, R., T. Ahsan, D. Larouche, P. Lévesque,
J. Dubé, F. A. Auger, R. M. Nerem, and L. Germain, A novel single-step self-assembly
approach for the fabrication of tissue-engineered vascular constructs, Online ahead of print,
Copyright (2010), with permission from Mary Ann Liebert; (b) Reprinted from
Biomaterials/31, Asakawa, N., T. Shimizu, Y. Tsuda, S. Sekiya, T. Sasagawa, M. Yamato,
F. Fukai, and T.Okano, Pre-vascularization of in vitro three-dimensional tissues created by
cell sheet engineering, 3903–3909, Copyright (2010), with permission from Elsevier; (c)
Reprinted from Tissue Eng. A, Hoganson, D. M., H. I. Pryor, I. D. Spool, O. H. Burns, J. R.
Gilmore, and J. P. Vacanti, Principles of biomimetic vascular network design applied to a
tissue-engineered liver scaffold, Online ahead of print, Copyright (2010) with permission
from Mary Ann Liebert.
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Continuously graded constructs for soft tissue—bone. (a) Immunohistochemical staining for
eGFP (pink) counterstained with hematoxylin (blue) revealed a gradient of Runx2—
expressing cells. (b) Mineral deposition via μCT after 42 days of in vitro culture. (c)
Mineral deposition via μCT after 2 weeks of ectopic in vivo implantation. The gradient
became steeper and more localized after in vivo culture. Scale bar = 2 mm. (a–c) Reprinted
from Proc. Natl. Acad. Sci./105 Phillips, J. E., K. L. Burns, J. M. Le Doux, R. E. Guldberg,
and A. J. García. Engineering graded tissue interfaces, 12170–12175, Copyright (2008)
National Academy of Sciences, U.S.A.
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Iterative design process for developing functional interfacial tissue solutions. Moving from
2D to in vivo environments requires constant characterization of each element (cells,
signals, and scaffolds), to find the simplest solution available for indications that interface-
relevant tissue is forming. Once reaching the in vivo stage, it will be important to formulate
scaffolds that are successful in tissue regeneration without cell transplantation, which will
require engineers to recollect the most critical design aspects thus far. One can begin the
design process anywhere in this schematic, but skipping 2D and 3D in vitro
characterizations may hinder the discovery of design parameters that are critical for success,
or allow for designs to carry superfluous factors to the final stage. Using continuously
graded scaffolds grants extra regenerative control to nature at this final stage.
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